altRX review
altRX is a dual-modality telehealth platform offering compounded GLP-1s plus all four brand-name FDA-approved options — Mounjaro, Ozempic, Wegovy, and Zepbound.
On the record
The FDA issued a warning letter to Trinity HealthCare Supply, LLC dba altRx in June 2026. altRX keeps its place here and its link is unchanged — but you should know the letter exists before you start care. Read it in the FDA's warning letter database.
- Semaglutide
- From $149/mo (starting dose, compounded)
- Tirzepatide
- From $249/mo (starting dose, compounded)
- Coverage
- Coverage not published
- Brand-name
- Yes
Prices read from altRX's own site on . Providers change pricing without notice — check the current figure before you buy.
The scorecard
altRX scored on our six Brief Score factors. See the methodology.
What we like
- Offers all four brand-name FDA-approved GLP-1s (Mounjaro, Ozempic, Wegovy, Zepbound) — the most comprehensive brand-name access we've reviewed
- Publishes the FDA compounded-medication disclaimer
- Transparent pricing across all six product tiers (compounded plus four brand-name)
- All-inclusive pricing — consult, prescription, and shipping with no hidden fees
The caveats
- States-served list not disclosed
- 503A/503B pharmacy partner not named (only 'multiple USA-certified pharmacies')
- 503A vs 503B designation not specified
- No named medical director
- FDA issued Trinity HealthCare Supply, LLC dba altRx a warning letter in June 2026; the letter is public in FDA's warning-letter database
The brief
Best for: Readers who want the only platform offering all four brand-name GLP-1s plus compounded. altRX is a dual-modality telehealth platform offering compounded GLP-1s plus all four brand-name FDA-approved options — Mounjaro, Ozempic, Wegovy, and Zepbound.
Ranked #253 of 546 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.
Before you decide
The questions readers ask next after reading about altRX.
Closest here
The providers scoring nearest altRX — the realistic shortlist if you're weighing it.
Weighing altRX against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs altRX, and every provider that outranks it is listed on the altRX alternatives ranking.
- #250VyrarX— VyrarX is a LegitScript-certified telehealth platform offering compounded semaglutide (from $179/month) and compounded tirzepatide (from $329/month) via weekly injection, prescribed by licensed US physicians.66/100
- #251Willow— Telehealth provider offering compounded GLP-1 medications in both tablet and injectable formats.66/100
- #252Pallas Health— A new provider that names six dispensing pharmacies and two NPI-verified prescribers — wrapped around a "$199/mo average" no monthly plan sells, because the bill is $597 every 12 weeks and 12 weeks is not three months.63/100
- #254Coby Health— Chicago/Springfield IL DTC telehealth marketplace (Coby Health LLC, BBB file opened 3/2025) offering compounded semaglutide from $99/mo (6-mo bundle, 0.25mg) and compounded tirzepatide from $179/mo.65/100
- #255EOS Health— EOS Health is a multi-vertical online telehealth service (weight loss, longevity, men's/women's health, skincare) offering compounded GLP-1 programs.65/100
- #256HeliMeds— HeliMeds offers compounded semaglutide and tirzepatide as well as brand-name Wegovy and Zepbound.65/100
More providers we track (24)
- #1 CoreAge Rx94
- #2 Eden91
- #3 Trimi89
- #4 Sesame Care87
- #5 ShedRx87
- #6 Sprout Health86
- #7 HealthRX86
- #8 MadeMed86
- #9 Invigor Medical88
- #10 Telos Rx85
- #11 Enhance MD85
- #12 REMEVi87
- #13 Ro87
- #14 Ondra Health87
- #15 Vaylen87
- #16 Vytora Health87
- #17 No BS RX87
- #18 yourEra84
- #19 Strut Health84
- #20 Effecty86
- #21 NiceRx86
- #22 Curex86
- #23 Amazon One Medical86
- #24 AgelessRx85
515 more are filed too — see every provider we track, ranked.
Pricing, states and verification reflect altRX's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on altRX's site. Not medical advice; see our disclosure.